Cellebrite DI Ltd.
CLBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $20,189 | $19,476 | $17,400 | $19,269 |
| Dep. & Amort. | $2,703 | $2,592 | $2,631 | $2,729 |
| Deferred Tax | -$51 | -$1,387 | -$386 | -$1,813 |
| Stock-Based Comp. | $0 | $0 | $8,777 | $9,269 |
| Change in WC | -$2,655 | $6,597 | -$4,641 | $40,215 |
| Other Non-Cash | $13,086 | $5,305 | -$2,903 | -$3,702 |
| Operating Cash Flow | $33,272 | $32,583 | $20,878 | $65,967 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,322 | -$3,608 | -$2,339 | -$3,178 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$111,057 | -$53,190 | -$213,956 | -$54,079 |
| Inv. Sales/Matur. | $190,544 | $63,370 | $89,791 | $42,447 |
| Other Inv. Act. | -$12,377 | $34,005 | $0 | -$1,139 |
| Investing Cash Flow | $63,788 | $40,577 | -$126,504 | -$15,949 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,267 | $13,826 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $3,620 | $6,730 |
| Financing Cash Flow | $5,267 | $13,826 | $3,620 | $6,730 |
| Forex Effect | -$189 | $1,762 | $822 | -$1,438 |
| Net Chg. in Cash | $102,138 | $88,748 | -$101,184 | $55,310 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $179,223 | $90,475 | $191,659 | $136,349 |
| End Cash | $281,361 | $179,223 | $90,475 | $191,659 |
| Free Cash Flow | $29,950 | $28,975 | $18,539 | $61,650 |